Research.Patient.info
Idiopathic Inflammatory Myopathy research hub
2 indexed studies · 1 currently recruiting
- recruitingPHASE2, PHASE3
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
This study looks at a new treatment called CABA-201 for conditions that cause muscle weakness and inflammation, like dermatomyositis. It aims to see how safe and effective this treatment is for adults and children whose condition hasn't improved with usual care.
United States · United Kingdom - authorisedPhase I and Phase II (Integrated)- Other
A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Active Idiopathic Inflammatory Myopathy or Active Juvenile Idiopathic Inflammatory Myopathy
This study is testing a new way to treat certain muscle diseases called inflammatory myopathies in adults and children. It looks at a special cell therapy (CABA-201) to see if it's safe and helps improve symptoms. Researchers want to understand how it affects the body.
Italy · Spain · Germany